Clinical Trials Sponsored by Reviva Pharmaceuticals

Total 20208 results

Barnes Retina Institute
Genentech, Inc.

Unknown

Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis

Presumed Ocular Histoplasmosis (POHS)

United States
Rejuva Medical Aesthetics
HealMD, LLC

Not yet recruiting

Evaluating Microneedling With CBD and Hempseed Oil for Acne Vulgaris Safety and Efficacy

Acne Vulgaris (Disorder)

United States
Levita Magnetics
The Cleveland Clinic

Recruiting

Clinical Evaluation of the Levita Robotic Platform

Bariatric Surgery Candidate | Cholelithiases | Other Disease

Chile
Retina Foundation of the Southwest

Active, not recruiting

Binocular iPad Sub-Study

Amblyopia

United States
Saskatchewan Health Authority - Regina Area

Active, not recruiting

Fundal Block in Pre-menopausal Women to Reduce Pain During Outpatient-based Endometrial Ablation (FUNDAL-PAIN) (FUNDAL-PAIN)

Pain

Canada
Regina Grossmann

Terminated

USZ BioResource COVID-19

COVID19

Switzerland
Retina Global
VisionQuest Biomedical LLC

Completed

The Santa Cruz Diabetic Retinopathy Utilizing Artificial Intelligence Study (SC-DRAI)

Diabetic Retinopathy

Bolivia
Saskatchewan Health Authority - Regina Area

Completed

Renal Denervation in Patients With Chronic Kidney Disease

Chronic Kidney Disease

Canada
Saskatchewan Health Authority - Regina Area

Withdrawn

Opioid Reduction Following Spinal Cord Stimulation (REDUCE)

Chronic Pain

Canada
Retina Foundation of the Southwest

Completed

Rod Sensitivity in Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP)

Retinitis Pigmentosa | AMD

United States
Wills Eye
Mid Atlantic Retina

Withdrawn

Quality and Diagnostic Utility of Mydriatic Fundus Plenoptic Photography (PORT)

Retinal Imaging

United States
Saskatchewan Health Authority - Regina Area

Completed

The Effect of Birth Plans on Obstetrical Outcomes

Pregnancy

Canada
Wills Eye
Retina Implant AG

Withdrawn

RETINA IMPLANT Alpha AMS in Blind Patients With Retinitis Pigmentosa

Retinitis Pigmentosa

United States
Retina-Vitreous Associates Medical Group

Completed

Long-Term Efficacy and Safety of Aflibercept Intravitreal Injections for the Treatment of Diabetic Macular Edema (Endurance3)

Clinically Significant Diabetic Macular Edema
Wills Eye
Mid Atlantic Retina

Completed

Eplerenone for the Treatment of Central Serous Chorioretinopathy

Central Serous Chorioretinopathy

United States
Regina Steringer-Mascherbauer

Unknown

Imaging Control Study, 3D Echo, MR and RHC. (PARIS)

Pulmonary Arterial Hypertension WHO Group I

Austria
Wills Eye
Mid Atlantic Retina

Completed

30g vs 33g Needle for Intravitreal Injections

Diabetic Macular Edema | Retinal Vein Occlusion | Age Related Macular Degeneration

United States
Saskatchewan Health Authority - Regina Area

Completed

Efficacy of Botulinum Toxin Type A for the Treatment of Non-neurogenic Urinary Urge Incontinence

Urinary Urge Incontinence

Canada
Wills Eye
Mid Atlantic Retina

Completed

Patient Comfort Using Green vs. Yellow Pan Retinal Photocoagulation

Proliferative Diabetic Retinopathy - High Risk

United States
Retina Clinic, Sao Paulo, Brazil

Completed

Automated Diagnostic Test for Diabetic Retinopathy in Brazilian Mass Screening

Diabetic Retinopathy

Brazil
California Retina Consultants
Genentech, Inc.

Completed

Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab (REEF)

Diabetic Macular Edema

United States
Retina Clinic, Sao Paulo, Brazil

Completed

Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema

Macular Edema

Brazil
Retina Associates of Florida, P.A.

Completed

REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study (Revolution)

Macular Edema | Branch Retinal Vein Occlusion

United States
Texas Retina Associates
Alcon Research

Completed

Prophylactic Anecortave Acetate in Patients With a Retisert Implant

Glaucoma | Uveitis, Posterior

United States
Regina Elena Cancer Institute
AstraZeneca

Unknown

A Study, Comparing a Dose-Titration Regimen of Fulvestrant With the Approved Dosing Regimen in Postmenopausal Patients With Hormone-Responsive Advanced Breast Cancer (ABC) (FIDeS)

Breast Cancer

Italy
University of Washington
Revivant Corporation

Terminated

AutoPulse Assisted Prehospital International Resuscitation Trial (ASPIRE)

Cardiac Arrest

United States
Portola Pharmaceuticals

Completed

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 3 of 4)

Healthy Volunteers

United States
Portola Pharmaceuticals

Withdrawn

CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL)

AITL | Peripheral T-Cell Lymphoma (PTCL NOS) | Nodal Lymphomas of T Follicular Helper (TFH) | Follicular T-cell Lymphoma (FTCL) | ALCL | HSTCL | EATL I,II | MEITL, EATL Type II | Nasal Lymphoma
Portola Pharmaceuticals

Completed

A Study in Older Subject to Evaluate the Safety and Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Rivaroxaban

Bleeding

United States
Regeneron Pharmaceuticals
Alnylam Pharmaceuticals

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Pozelimab in Combination With Cemdisiran in Healthy Adult Volunteers

Healthy

Belgium
Ferring Pharmaceuticals
Xanodyne Pharmaceuticals

Completed

A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding

Menorrhagia

United States
ISA Pharmaceuticals
Regeneron Pharmaceuticals

Active, not recruiting

A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

Squamous Cell Carcinoma of the Oropharynx | HPV16 Positive

Netherlands, United States, United Kingdom, France, Belgium, Czechia, Spain, Italy, Germany, Brazil, Hungary, Mexico, Poland
Portola Pharmaceuticals

Completed

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 2 of 4)

Healthy Volunteers
Portola Pharmaceuticals

Completed

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 4 of 4)

Healthy Volunteers
Portola Pharmaceuticals

Completed

The Effect o f Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Betrixiban, an Oral FXa Antagonist

Hepatic Impairment

United States
Portola Pharmaceuticals

Withdrawn

BRAVO - Betrixaban Registry Using Real Time Observations in Acute Medical Illness to Assess Venous Thrombosis and Bleeding Outcomes

Venous Thromboses

United States
Jazz Pharmaceuticals
GW Pharmaceuticals

Completed

An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

Seizures | Tuberous Sclerosis Complex

United States
Solvay Pharmaceuticals
Unimed Pharmaceuticals

Completed

Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism

Primary or Secondary Hypogonadism | Constitutional Delay in Growth and Puberty (CDGP)

United States
Solvay Pharmaceuticals
Unimed Pharmaceuticals

Completed

Pharmacokinetic Evaluation of Testosterone Gel (1%)

Primary or Secondary Hypogonadism | Constitutional Delay in Growth and Puberty (CDGP)

United States
ISA Pharmaceuticals
Regeneron Pharmaceuticals

Active, not recruiting

A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC

Squamous Cell Carcinoma of the Oropharynx

United States, Israel, Belgium, Germany, Spain, United Kingdom, Italy, France, Czechia
Portola Pharmaceuticals

Completed

A Healthy Volunteer Pharmacokinetics (PK)/Pharmacodynamics (PD), Safety and Tolerability Study of Andexanet in Healthy Japanese and Caucasian Subjects

Bleeding

United States
Jazz Pharmaceuticals
GW Pharmaceuticals

Terminated

A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome

Rett Syndrome | RTT

United States, Canada, Italy, Spain, United Kingdom, Australia
Alexion Pharmaceuticals
Portola Pharmaceuticals

Completed

Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL

Follicular Lymphoma (FL/Indolent NHL) | Aggressive NHL (a NHL) | Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) | T-cell Lymphoma (PTCL and CTCL) | B-cell Non Hodgkin Lymphoma (NHL)

United States
EVIVE Biotechnology
Fudan University

Completed

Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Breast Cancer | Neutropenia
NovaBay Pharmaceuticals, Inc.
Novum Pharmaceutical Research Services; International Dermatology Research,...

Completed

Safety and Efficacy of Topical NVC-422 Gel in Impetigo

Impetigo

Dominican Republic
PETHEMA Foundation
Millennium Pharmaceuticals, Inc.; Johnson & Johnson Pharmaceutical Research...

Completed

Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.

Multiple Myeloma

Spain
Reia, LLC

Completed

Early Feasibility Study of the Reia Vaginal Pessary

Pelvic Organ Prolapse | Prolapse

United States
Douglas Pharmaceuticals America Ltd
Novum Pharmaceutical Research Services; ACM Global Laboratories

Completed

A Therapeutic Equivalence Study of Ketoconazole Cream 2%

Tinea Pedis

Belize, United States
Xavier Corominas

Recruiting

Clinical, Electrophysiological and E-field Modelling Evidence of High Density Transcranial Direct Current Stimulation in Motor Stroke (E-brain)

Stroke

Spain
University of Regina
Government of Canada

Completed

Exploring the Role of Online Discussion Forums in Internet-Delivered Therapy for Canadian Public Safety Personnel

Depression | Stress Disorders, Post-Traumatic | Anxiety

Canada

Clinical Trials Sponsored by Reviva Pharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations